Conference Coverage

TAVR shows large survival benefit in diabetes patients


 

AT THE ESC CONGRESS 2013

The PARTNER trial was sponsored by Edwards Lifesciences, which markets the TAVR device used in the study. Dr. Lindman was an investigator in PARTNER and said that he had no disclosures.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Early thrombolysis benefits moderate and mild stroke patients
MDedge Family Medicine
Acute onset arthritis possible with clopidogrel
MDedge Family Medicine
Fruits, not vegetables, seen to lower AAA risk
MDedge Family Medicine
PCI in noninfarct coronaries helps STEMI patients
MDedge Family Medicine
Prasugrel pretreatment ups bleeding risk in NSTE ACS
MDedge Family Medicine
TASTE: Thrombus aspiration has no mortality benefit in STEMI
MDedge Family Medicine
Registry-based randomized clinical trials are here
MDedge Family Medicine
High-volume, low-mortality hospitals have lowest postsurgical readmissions
MDedge Family Medicine
ECG leads were misplaced in 3% of children in a single-center study
MDedge Family Medicine
FDA drops access points from Sapien transcatheter valve label
MDedge Family Medicine